MedPath

A clinical trial to study the safety and efficacy of the LightSheer Duet 1060nm HS laser system

Not Applicable
Registration Number
CTRI/2014/01/004292
Lead Sponsor
umenis India Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
25
Inclusion Criteria

Healthy adult, females or males (at least 80% female) older than 18 years of age with skin type I-VI; Having at least two suitable treatment areas for hair removal with dark brown or black hair;

Exclusion Criteria

•Active infections;

•Dysplastic nevi;

•Tattoos;

•Significant concurrent skin conditions or any inflammatory skin conditions;

•Active cold sores, open lacerations or abrasions;

•Chronic or cutaneous viral, fungal, or bacterial diseases;

•Deep suntan, recent suntan, sunburn or artificially tanned skin;

•Current skin cancer

•Treatment should not be attempted on patients with a history of skin cancer or pre-cancerous lesions at the treatment areas;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy <br/ ><br>Demonstrate temporary hair removal 4-6 weeks following 3 treatments. <br/ ><br>Safety <br/ ><br>To evaluate the safety of hair removal using the LightSheer Duet 1060nm in Fitzpatrick I-VI and tanned skin types. <br/ ><br>Timepoint: Post Treatment 3
Secondary Outcome Measures
NameTimeMethod
â?¢Demonstrate temporary hair removal 3 month following 5 treatments. <br/ ><br>â?¢Demonstrate permanent hair reduction 6 months following 5 treatments. <br/ ><br>â?¢Evaluate the immediate response following treatment as well as the subjectâ??s perception of the treatment. <br/ ><br>â?¢Evaluate hair coarseness and color. <br/ ><br>â?¢Evaluate length of the treatment. <br/ ><br>â?¢Evaluate the tissue alterations at the follicular level.Timepoint: 3 and 6 months post Treatment 5
© Copyright 2025. All Rights Reserved by MedPath